peter attia tirzepatide New insights on GLP-1 agonists—Ozempic, Wegovy, Mounjaro, and more (AMA 64 sneak peek) Does Peter Attia's Longevity Plan

Call (520) 298-3300

Follow up appointments with your provider Schedule follow up appointments with your healthcare provider to ensure continuous care and monitoring

Medical Weight Loss Start your weight loss journey today Book a consultation to discuss GLP-1 medications, personalized nutrition, and physician-supervised weight management

Active-duty members must be particularly cautious to ensure their treatment is documented and approved to avoid administrative pitfalls

As glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and newer dual- or tri-receptor agonists (incretin mimetics) redefine metabolic health management, oncology clinicians increasingly face questions about their use during and after active cancer treatment

Mounjaro is a dual GIP and GLP-1 receptor agonist licensed in the UK for chronic weight management in adults with obesity or overweight with weight-related comorbidities, as well as for type 2 diabetes